Tools

GlaxoSmithKline Plc’s diabetes pill Avandia came under intense scrutiny on both sides of the Atlantic on Friday, leaving the drug’s… »   

Defeating the flu is challenging because the virus responsible for the disease undergoes frequent changes of its genetic code, making… »   

Timothy S. Tracy, professor and head of the Department of Experimental and Clinical Pharmacology at the University of Minnesota College… »   

Johnson & Johnson’s string of product recalls grew on Thursday as the company recalled 21 more lots of Tylenol… »   

The first of three new fat-fighting pills faces public scrutiny by U.S. regulatory advisers next week, as small biotechs target… »   

An ultra-low-molecular-weight heparin called semuloparin has been found to reduce the incidence of venous thromboembolism in orthopedic surgery patients in… »   

Pfizer Inc, the world’s leading biopharmaceutical company, today announced that the results of a number of hemophilia studies will be… »   

Major drug companies have agreed to help the World Anti-Doping Agency (WADA) identify medicinal compounds that have the potential… »   

A popular anti-arthritis supplement may not help most people with low back pain, according to a new study. Patients in… »   

Novartis AG’s cancer drug Afinitor has been rejected for patients with kidney cancer by Britain’s health costs watchdog, which… »